Literature DB >> 2513473

Measles prevention.

.   

Abstract

These revised recommendations of the Immunization Practices Advisory Committee (ACIP) on Measles Prevention replace previous recommendations published in 1987 (1) and 1989 (2). The recommendations include a basic change in the routine childhood vaccination schedule from a one-dose to a two-dose schedule using combined measles-mumps-rubella (MMR) vaccine. Routine revaccination will generally be implemented one age group at a time starting with school enterers. New recommendations are also included for vaccination of preschool children at high risk of contracting measles, for students in colleges and other institutions of higher education, for health-care personnel and international travelers, and for outbreak control.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2513473

Source DB:  PubMed          Journal:  MMWR Suppl        ISSN: 2380-8942


  16 in total

1.  Can HB vaccine yield a booster effect on individuals with positive serum anti-HBs and anti-HBc markers?

Authors:  Ru-Xiang Wang; Ying Guo; Chang-Hong Yang; Yu Song; Juan Chen; Fu-Sheng Pang; Shao-Ping Lei; Xiao-Ming Jia; Jin-Ying Wen; Christina Y Shi
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

2.  Cost of Responding to the 2017 University of Washington Mumps Outbreak: A Prospective Analysis.

Authors:  Jamison Pike; Sheryl Schwartz; Meagan Kay; Ailyn Perez-Osorio; Mona Marin; Mark Jenkins; Janell Routh; Jeff Duchin; Chas DeBolt; Fangjun Zhou
Journal:  J Public Health Manag Pract       Date:  2020 Mar/Apr

3.  Estimates of mumps seroprevalence may be influenced by antibody specificity and serologic method.

Authors:  Donald R Latner; Marcia McGrew; Nobia J Williams; Sun B Sowers; William J Bellini; Carole J Hickman
Journal:  Clin Vaccine Immunol       Date:  2013-12-26

4.  MMR Vaccine: When Is the Right Time for the Second Dose?

Authors:  Oscar R Herrera; Terrika A Thornton; Richard A Helms; Stephan L Foster
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Mar-Apr

5.  Missed Opportunities for Measles, Mumps, Rubella Vaccination Among Departing U.S. Adult Travelers Receiving Pretravel Health Consultations.

Authors:  Emily P Hyle; Sowmya R Rao; Emily S Jentes; Amy Parker Fiebelkorn; Stefan H F Hagmann; Allison Taylor Walker; Rochelle P Walensky; Edward T Ryan; Regina C LaRocque
Journal:  Ann Intern Med       Date:  2017-05-16       Impact factor: 25.391

6.  Environmental factors potentially associated with mumps transmission in yeshivas during a mumps outbreak among highly vaccinated students: Brooklyn, New York, 2009-2010.

Authors:  Amy Parker Fiebelkorn; Jennifer B Rosen; Cedric Brown; Christopher M Zimmerman; Hyman Renshowitz; Christopher D'Andrea; Kathleen M Gallagher; Rafael Harpaz; Jane R Zucker
Journal:  Hum Vaccin Immunother       Date:  2013-01       Impact factor: 3.452

Review 7.  Mumps: an Update on Outbreaks, Vaccine Efficacy, and Genomic Diversity.

Authors:  Eugene Lam; Jennifer B Rosen; Jane R Zucker
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

8.  Clinical Practices for Measles-Mumps-Rubella Vaccination Among US Pediatric International Travelers.

Authors:  Emily P Hyle; Sowmya R Rao; Audrey C Bangs; Paul Gastañaduy; Amy Parker Fiebelkorn; Stefan H F Hagmann; Allison Taylor Walker; Rochelle P Walensky; Edward T Ryan; Regina C LaRocque
Journal:  JAMA Pediatr       Date:  2020-02-03       Impact factor: 16.193

9.  Double outbreak of measles in the talaja block of bhavnagar district, gujarat, India 2011: a need for improving the vaccine coverage and the community participation.

Authors:  Pankhuri P Mishra; Naresh T Chauhan
Journal:  J Clin Diagn Res       Date:  2012-12-15

10.  Mumps Outbreak in a Highly Vaccinated University-Affiliated Setting Before and After a Measles-Mumps-Rubella Vaccination Campaign-Iowa, July 2015-May 2016.

Authors:  Minesh Shah; Patricia Quinlisk; Andrew Weigel; Jacob Riley; Lisa James; James Patterson; Carole Hickman; Paul A Rota; Rebekah Stewart; Nakia Clemmons; Nicholas Kalas; Cristina Cardemil
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.